Vertex Pharmaceuticals ( VRTX +1.27%) and Mirum Pharmaceuticals ( MIRM +2.18%) are two biotech stocks that share the same ...
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Stocktwits on MSN
TRVI stock’s five-day rally pushes it to an all-time high – here’s what’s happening
Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...
This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...
Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...
Scientists now recognize that spontaneous DNA errors, which we acquire in early development all the way until our last breath ...
Morning Overview on MSN
Study of immune memory points to new paths against deadly disease
A macrophage that has already fought off one infection does not return to a blank slate. It carries chemical scars, etched ...
John Stamos shared his pride in how the child stars of FULL HOUSE “turned out.” “Can I say how proud I am of her?” he said ...
Cautionary Language Concerning Forward-Looking Statements ...
FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results